PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis

Renato Lobrano, Panagiotis Paliogiannis, Angelo Zinellu, Giuseppe Palmieri, Ivana Persico, Arduino A. Mangoni, Antonio Cossu

Research output: Contribution to journalReview articlepeer-review

8 Downloads (Pure)


Cutaneous angiosarcoma (CAS) is the most common type of angiosarcoma that predominantly affects older Caucasians. The outcomes of immunotherapy in CAS are currently under investigation in relation to the expression of programmed death ligand 1 (PD-L1) and other biomarkers. We performed a systematic review and metanalysis of data from the current literature reporting on PD-L1 immunohistochemistry expression. A systematic search of publications in the electronic databases PubMed, Web of Science, and Scopus was conducted using the following terms: “PD-L1” and “angiosarcomas”. A total of ten studies reporting on 279 cases were identified and included in the meta-analysis. The pooled prevalence of PD-L1 expression in CAS was 54% (95% CI 36–71%), with high heterogeneity (I2 = 84.81%, p < 0.001). In sub-group analysis, the proportion of PD-L1 expression in CAS was significantly (p = 0.049) lower in Asian studies (ES = 35%, 95% CI 28–42%, I2 = 0.0%, p = 0.46) than in European studies (ES = 71%, 95% CI 51–89%, I2 = 48.91%, p = 0.12).

Original languageEnglish
Pages (from-to)5135-5144
Number of pages10
JournalCurrent Oncology
Issue number5
Publication statusPublished - May 2023


  • cancer
  • cutaneous angiosarcomas
  • immunohistochemistry
  • immunotherapy
  • PD-L1
  • skin


Dive into the research topics of 'PD-L1 Expression in Cutaneous Angiosarcomas: A Systematic Review with Meta-Analysis'. Together they form a unique fingerprint.

Cite this